TTBK2 antisense RNA 1 (TTBK2-AS1)

**TTBK2 antisense RNA 1 (TTBK2-AS1)** is classified as a natural antisense long non-coding RNA (lncRNA). Antisense lncRNAs are transcribed from the opposite strand of corresponding protein-coding genes and are known to regulate gene expression at various levels, including transcription, splicing, translation, and epigenetic modification[4]. While antisense lncRNAs as a family are increasingly recognized for roles in cancer biology, gene regulation, and cellular phenotypes, specific evidence for TTBK2-AS1’s biological function, disease relevance, or therapeutic applications is lacking as of the current literature. Its nomenclature (TTBK2-AS1) denotes that it is an antisense transcript overlapping or near the TTBK2 protein-coding gene, but unique functional or disease linkage for this specific lncRNA has not been established in published studies[4]. There are currently no known drugs, biomarker uses, or safety concerns associated with TTBK2-AS1. Key conventions: - TTBK2-AS1 should not be confused with the protein-coding TTBK2 (Tau tubulin kinase 2), which is an enzyme and disease target in neurodegeneration. - TTBK2-AS1 is not a receptor, enzyme, transporter, or conventional small-molecule drug target (e.g., no receptor, kinase, or “classic druggable” activity)[4]. If structured information or more detailed biological data becomes available for TTBK2-AS1, these entries should be updated.